Entity
Company
Location
345 Park Avenue South, 12 Th Floor, New York, NY
Signature
/s/ Jonathan Isler, Attorney-in-Fact for Deerfield Management Company, L.P.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Deerfield Management Company, L.P. (Series C):

Stock Role Class Num Shares Value Price $ Report Date Ownership
DA32 Life Science Tech Acquisition Corp. Director, Director by Deputization, 10%+ Owner Class A Common Stock 650K $6.5M $10.00 Jul 28, 2023 Through DA32 Sponsor LLC
DA32 Life Science Tech Acquisition Corp. Director, Director by Deputization, 10%+ Owner Class A Common Stock 0 $10.00 Jul 28, 2023 Through Deerfield Partners, L.P.

Insider Reports Filed by Deerfield Management Company, L.P. (Series C)

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DALS DA32 Life Science Tech Acquisition Corp. Jul 28, 2023 1 $0 4 Aug 1, 2023 Director, Director by Deputization, 10%+ Owner
DALS DA32 Life Science Tech Acquisition Corp. Aug 5, 2021 1 $0 4 Aug 9, 2021 Director, Director by Deputization, 10%+ Owner
DALS DA32 Life Science Tech Acquisition Corp. Jul 30, 2021 2 $22.5M 4 Aug 3, 2021 Director, Director by Deputization, 10%+ Owner
DALS DA32 Life Science Tech Acquisition Corp. Jul 27, 2021 0 $0 3 Jul 27, 2021 Director, Director by deputization, 10%+ Owner